Coastal Infusion Administers Benlysta

Benlysta (belimumab) is used to treat lupus, a chronic autoimmune disease that causes inflammation and damage to various parts of the body. Benlysta is used as an add-on treatment in patients with systemic lupus erythematosus (SLE).

The active substance in Benlysta, belimumab, is a monoclonal antibody, a protein that has been designed to attach to and block a protein called BLyS which helps B lymphocytes to live longer. By blocking the action of BLyS, belimumab reduces the life span of B lymphocytes, thereby reducing the inflammation and organ damage that occur in SLE.

Benlysta is typically used in patients who have not responded well to other treatments, and whose disease is still highly active despite standard treatment.

What It Treats

Apretued is used to treat systemic lupus erythematosus (SLE).

Prescribed By

Benlysta is most often prescribed by Rheumatologists.

How it’s Administered

Benlysta is administered by intravenous infusion or subcutaneous injection. Benlysta injections take only a few minutes. Infusions take about an hour.

Frequency

Benlysta infusions are given every 2 weeks for the first 3 doses, followed by infusion every 4-weeks. Injections are givien once a week.

Related Drugs

Saphnelo

Additional Resources

• Benlysta Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies